Financhill
Back

Astrana Health Vs. Blueprint Medicines Industry Stock Comparison

Sell
24

ASTH
Astrana Health

Last Price:
$31.1500
Seasonality Move:
4.29%
Sell
43

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
24
Astrana Health (ASTH) is a Sell

Is Astrana Health a Buy, Sell or Hold?

  • The current Astrana Health [ASTH] share price is $30.2800. The Score for ASTH is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ASTH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASTH Stock Price Chart

What is Astrana Health's stock price today?

  • The Astrana Health share price today is $30.2800
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $103.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ASTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3 Sell
Relative Strength Index (14 RSI): 25.38 Sell
Chaikin Money Flow: 133096 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.1702 - 38.3302) Sell
Bollinger Bands (100): (38.0648 - 56.9848) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 65.19 Buy
Chaikin Money Flow: 1951173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.25 - 95.81) Buy
Bollinger Bands (100): (87.04 - 95.76) Buy

ASTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.22 Sell
20-day SMA: 33.32 Sell
50-day SMA: 40.64 Sell
200-day SMA: 44.92 Sell
8-day EMA: 31.23 Sell
20-day EMA: 33.67 Sell
50-day EMA: 39.33 Sell
200-day EMA: 43.74 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.01 Buy
20-day SMA: 91.26 Buy
50-day SMA: 93.56 Buy
200-day SMA: 96.81 Buy
8-day EMA: 92.7 Buy
20-day EMA: 91.91 Buy
50-day EMA: 92.32 Buy
200-day EMA: 91.6 Buy

Astrana Health Earnings Growth & ASTH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.50 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Astrana Health Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):